EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mitochondrial Genetic Diseases and Ophthalmic Manifestations: Molecular Pathophysiology, Genetics, and Clinical Management

Khaled K Abu-Amero

International Journal of Molecular Sciences · 09.07.2026 · 27 (14) · 6128

DOI: 10.3390/ijms27146128 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.07.2026. Verfasst von Khaled K Abu-Amero. Beteiligte Einrichtung: Research Department, King Khaled Eye Specialist Hospital and Research Center, Riyadh 11462, Saudi Arabia. Hauptthemen laut MEDLINE: Mitochondrial Diseases, Eye Diseases. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial genetic disorders compromise oxidative phosphorylation (OXPHOS) and cellular energy supply, and the eye is among the first organs to feel the deficit. Photoreceptors and retinal ganglion cells (RGCs) sustain among the highest metabolic rates in the body, so ophthalmic features often dominate the clinical picture and arrive before systemic disease is recognized. More than half of all patients with confirmed mitochondrial disease develop sight-threatening complications. This review integrates mtDNA and nuclear genetics; ophthalmic and extraocular phenotypes; the bioenergetic and apoptotic mechanisms that drive vision loss; the clinical examination and investigations that delineate the problem; the differential diagnoses that must be excluded; the contribution of common mtDNA haplogroup variation to age-related retinal disease; and the diagnostic, therapeutic, and counseling approaches that turn a molecular result into useful care. Recurring themes are heteroplasmy, the threshold effect, and the selective vulnerability of RGCs and extraocular muscle across genetically distinct disorders. Treatment remains largely supportive, but idebenone, gene therapy, mitophagy modulation, and targeted antioxidants now offer mechanism-based intervention for several ophthalmic manifestations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitochondrial DiseasesEye DiseasesHumansDNA, MitochondrialMitochondriaAnimalsOxidative Phosphorylation

Stichwörter der Autor:innen

clinical managementdiseasesgeneticsmitochondriaophthalmologyoxidative stress

Substanzen

DNA, Mitochondrial

Autor:innen und Institutionen

  • Research Department, King Khaled Eye Specialist Hospital and Research Center, Riyadh 11462, Saudi Arabia.

Zitieren

APA

Abu-Amero, K. K. (2026). Mitochondrial Genetic Diseases and Ophthalmic Manifestations: Molecular Pathophysiology, Genetics, and Clinical Management. International Journal of Molecular Sciences, 27(14), 6128. https://doi.org/10.3390/ijms27146128

Vancouver

Abu-Amero KK. Mitochondrial Genetic Diseases and Ophthalmic Manifestations: Molecular Pathophysiology, Genetics, and Clinical Management. International Journal of Molecular Sciences. 2026;27(14):6128. doi:10.3390/ijms27146128

BibTeX
@article{AbuAmero2026,
  author = {Abu-Amero, Khaled K},
  title = {Mitochondrial Genetic Diseases and Ophthalmic Manifestations: Molecular Pathophysiology, Genetics, and Clinical Management},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {14},
  pages = {6128},
  doi = {10.3390/ijms27146128}
}
Kostenlos starten →